AbbVie Inc (ABBV)

Index:

S&P 100

$ 262.82
   
  • Change Today:
    $2.89
  • 52 Week High: $266.28
  • 52 Week Low: $197.38
  • Currency: US Dollars
  • Shares Issued: 1,767.88m
  • Volume: 5,863,068
  • Market Cap: $464,633m
  • RiskGrade: 122

Latest ShareCast News

AbbVie to buy biotech firm Apogee Therapeutics for $10.9bn

By Michele Maatouk

Date: Monday 22 Jun 2026

(Sharecast News) - AbbVie said on Monday that it has agreed to buy clinical-stage biotechnology company Apogee Therapeutics for $10.9bn.

AbbVie Inc ShareCast News

First Development Resources reports encouraging ... 19-Feb-2026 ShareCast
AstraZeneca sells hypertension drug rights; End... 27-Jan-2020 ShareCast
Botox maker Allergan reports jump in third-quart... 05-Nov-2019 ShareCast
Abbvie snaps up Botox-maker Allergan in $63bn deal 25-Jun-2019 ShareCast
Pharma firms to testify in Congress over drug pr... 26-Feb-2019 ShareCast

AbbVie Inc Newspaper Links

Abbvie boss blasts US tax regime 21-Oct-2014 Telegraph
Drug company AbbVie takeover rival in £31bn bid 18-Jul-2014 Express & Star
AbbVie to announce firm bid for Shire 18-Jul-2014 Telegraph
AbbVie's raised proposal for Shire gets board ba... 15-Jul-2014 Guardian
Shire set to accept £31bn bid from US rival AbbVie 15-Jul-2014 Express & Star

AbbVie Inc Tips & Analysis

No recent information was found.

AbbVie Inc News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AbbVie Inc Market Data

Currency US Dollars
Share Price $ 262.82
Change Today $ 2.89
% Change 1.11 %
52 Week High $266.28
52 Week Low $197.38
Volume 5,863,068
Shares Issued 1,767.88m
Market Cap $464,633m
RiskGrade 122

Trades for 02-Oct-2026

Time Volume / Share Price
16:02 1,076,880 @ $262.82
16:00 1,365 @ $263.03
16:00 100 @ $263.03
16:00 100 @ $263.03
16:00 100 @ $262.90

Top of Page